Draft:Dr. Smile Medical Group
Submission declined on 22 July 2024 by SafariScribe (talk). This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources. This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are:
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
| ![]() |
Submission declined on 22 July 2024 by Iwaqarhashmi (talk). This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources. Declined by Iwaqarhashmi 32 days ago. | ![]() |
Dr. Smile Medical Group, established on July 1, 2014, and headquartered in Shanghai, is China’s first medical group. Founded by the esteemed vascular surgeon Dr. Smile Chang(张强医生), the group has extended its network to major cities including Shanghai, Beijing, Shenzhen, and Chengdu,Jinan,among others. In 2023, the group made a significant stride by opening its first international CHIVA center for varicose vein treatment in Africa, followed by an ambitious global expansion in 2024.
Pioneering in its field, Dr. Smile Medical Group is recognized as the first Chinese medical team to lead and manage the international certification of CHIVA, a specialized global clinical technique. It presides as the primary committee member of the national professional committee for venous diseases and spearheads national medical continuing education projects in this domain. As the host of the Global Venous Forum (GVF) and the online education platform for the Si-Jun International Academy of Venous Diseases, the Group has been instrumental in introducing and adopting various innovative treatment technologies for varicose veins in China, such as Sclerotherapy Endoscopic Perforator Surgery (SEPS), intravenous radiofrequency ablation, and CHIVA.
References
[edit]1. Offical Website 2. Conference Preview: 2023 Global Venous Forum (GVF) in China 3. Global CHIVA Education, Training, and Certification Program